Top Markets
Coin of the day
Algorae Pharmaceuticals Limited Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited

1AI
Rankning i aktier #30360
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Aktiekurs
$0.00846342
Marknadsvärde
$17.16M
Förändring (1 dag)
9.09%
Förändring (1 år)
87.30%
Land
AU
Handel Algorae Pharmaceuticals Limited (1AI)

Kategori

Aktiekurshistorik för Algorae Pharmaceuticals Limited (1AI)
Högsta slutkurs: $0.01 den 2026-08-01

Lägsta slutkurs: $0.01 den 2023-08-01
Aktiekurshistorik för Algorae Pharmaceuticals Limited från 2023 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -10.71%
2025 104.60%
2024 -39.97%
2023 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$115.74 -20.49%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE